Fatty acid amides (FAAs) are an emerging family of endogenous signaling lipids implicated in a broad range of physiological processes, including pain, inflammation, and drug addiction. A prototype FAA anandamide serves as an endogenous ligand for the central cannabinoid (CB1) receptor. Although anandamide binds and activates the CB1 receptor in vitro, this FAA induces only weak cannabinoid behavioral effects in vivo due to rapid catabolism. The objective of this proposal is to identify and characterize enzymes that regulate the function of anandamide and other bioactive FAAs in vivo. One candidate enzyme responsible for terminating FAA signals in vivo is fatty acid amide hydrolase (FAAH), which hydrolyzes anandamide and related FAAs in vitro. To test the role that FAAH plays in regulating FAA function in vivo, we have created FAAH-knockout [FAAH(-/-)] mice. FAAH(-/-) mice possess greatly increased endogenous brain levels of anandamide (and other FAAs) and display reduced pain sensation that is reversed by CB1 antagonists. These data indicate that FAAH is a key regulator of FAA signaling in vivo, setting an endocannabinoid (EC) tone that modulates pain perception. More recently, we have devised a transgenic method to restrict the expression of FAAH to specific tissues, allowing us to determine that peripheral FAAs regulate inflammation through a CB receptor-independent mechanism. In this application, we propose to extend our analysis of transgenic FAAH mouse models to examine the role that the EC/FAA system play in multiple forms of acute and chronic inflammatory pain. Additionally, building on our recent discovery of a mutation in the human FAAH gene linked to problem drug use, we will compare the drug dependence and withdrawal responses of FAAH(+/+) and (-/-) mice. Finally, we will create and analyze knockout mice lacking candidate FAA biosynthetic enzymes. These studies will elucidate the functions of key enzymes that regulate FAA signaling in vivo. These proteins may represent new targets for the treatment of pain, addiction, and other neurological disorders.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA015197-05
Application #
7082959
Study Section
Molecular Neuropharmacology and Signaling Study Section (MNPS)
Program Officer
Rapaka, Rao
Project Start
2002-04-01
Project End
2010-06-30
Budget Start
2006-07-01
Budget End
2007-06-30
Support Year
5
Fiscal Year
2006
Total Cost
$314,078
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
781613492
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Nass, Sara R; Long, Jonathan Z; Schlosburg, Joel E et al. (2015) Endocannabinoid Catabolic Enzymes Play Differential Roles in Thermal Homeostasis in Response to Environmental or Immune Challenge. J Neuroimmune Pharmacol 10:364-70
Schlosburg, Joel E; Kinsey, Steven G; Ignatowska-Jankowska, Bogna et al. (2014) Prolonged monoacylglycerol lipase blockade causes equivalent cannabinoid receptor type 1 receptor-mediated adaptations in fatty acid amide hydrolase wild-type and knockout mice. J Pharmacol Exp Ther 350:196-204
Kinsey, Steven G; Wise, Laura E; Ramesh, Divya et al. (2013) Repeated low-dose administration of the monoacylglycerol lipase inhibitor JZL184 retains cannabinoid receptor type 1-mediated antinociceptive and gastroprotective effects. J Pharmacol Exp Ther 345:492-501
Wise, Laura E; Long, Kelly A; Abdullah, Rehab A et al. (2012) Dual fatty acid amide hydrolase and monoacylglycerol lipase blockade produces THC-like Morris water maze deficits in mice. ACS Chem Neurosci 3:369-78
Gamage, Thomas F; Lichtman, Aron H (2012) The endocannabinoid system: role in energy regulation. Pediatr Blood Cancer 58:144-8
Ramesh, Divya; Schlosburg, Joel E; Wiebelhaus, Jason M et al. (2011) Marijuana dependence: not just smoke and mirrors. ILAR J 52:295-308
Kinsey, Steven G; Nomura, Daniel K; O'Neal, Scott T et al. (2011) Inhibition of monoacylglycerol lipase attenuates nonsteroidal anti-inflammatory drug-induced gastric hemorrhages in mice. J Pharmacol Exp Ther 338:795-802
Kinsey, Steven G; Naidu, Pattipati S; Cravatt, Benjamin F et al. (2011) Fatty acid amide hydrolase blockade attenuates the development of collagen-induced arthritis and related thermal hyperalgesia in mice. Pharmacol Biochem Behav 99:718-25
Ezzili, Cyrine; Mileni, Mauro; McGlinchey, Nicholas et al. (2011) Reversible competitive ýý-ketoheterocycle inhibitors of fatty acid amide hydrolase containing additional conformational constraints in the acyl side chain: orally active, long-acting analgesics. J Med Chem 54:2805-22
Schlosburg, Joel E; O'Neal, Scott T; Conrad, Daniel H et al. (2011) CB1 receptors mediate rimonabant-induced pruritic responses in mice: investigation of locus of action. Psychopharmacology (Berl) 216:323-31

Showing the most recent 10 out of 64 publications